1. Home
  2. JRVR vs HRTX Comparison

JRVR vs HRTX Comparison

Compare JRVR & HRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JRVR
  • HRTX
  • Stock Information
  • Founded
  • JRVR 2002
  • HRTX 1983
  • Country
  • JRVR Bermuda
  • HRTX United States
  • Employees
  • JRVR N/A
  • HRTX N/A
  • Industry
  • JRVR Property-Casualty Insurers
  • HRTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • JRVR Finance
  • HRTX Health Care
  • Exchange
  • JRVR Nasdaq
  • HRTX Nasdaq
  • Market Cap
  • JRVR 270.4M
  • HRTX 242.0M
  • IPO Year
  • JRVR 2005
  • HRTX 1987
  • Fundamental
  • Price
  • JRVR $5.23
  • HRTX $1.29
  • Analyst Decision
  • JRVR Buy
  • HRTX Strong Buy
  • Analyst Count
  • JRVR 4
  • HRTX 2
  • Target Price
  • JRVR $6.06
  • HRTX $4.50
  • AVG Volume (30 Days)
  • JRVR 184.1K
  • HRTX 1.5M
  • Earning Date
  • JRVR 11-03-2025
  • HRTX 11-11-2025
  • Dividend Yield
  • JRVR 0.76%
  • HRTX N/A
  • EPS Growth
  • JRVR N/A
  • HRTX N/A
  • EPS
  • JRVR N/A
  • HRTX N/A
  • Revenue
  • JRVR $665,342,000.00
  • HRTX $149,694,000.00
  • Revenue This Year
  • JRVR $2.19
  • HRTX $10.62
  • Revenue Next Year
  • JRVR $7.93
  • HRTX $12.99
  • P/E Ratio
  • JRVR N/A
  • HRTX N/A
  • Revenue Growth
  • JRVR N/A
  • HRTX 9.78
  • 52 Week Low
  • JRVR $3.00
  • HRTX $1.04
  • 52 Week High
  • JRVR $7.19
  • HRTX $2.68
  • Technical
  • Relative Strength Index (RSI)
  • JRVR 41.69
  • HRTX 46.69
  • Support Level
  • JRVR $5.07
  • HRTX $1.28
  • Resistance Level
  • JRVR $5.50
  • HRTX $1.38
  • Average True Range (ATR)
  • JRVR 0.19
  • HRTX 0.06
  • MACD
  • JRVR -0.03
  • HRTX 0.01
  • Stochastic Oscillator
  • JRVR 18.23
  • HRTX 41.94

About JRVR James River Group Holdings Ltd.

James River Group Holdings Ltd owns and operates a group of specialty insurance and reinsurance companies. It reports business into three segments. The Excess and Surplus Lines segment, which is the key revenue driver, offers commercial excess and surplus lines liability and excess property insurance products; The Specialty Admitted Insurance segment focuses on niche classes within the standard insurance markets with a primary focus on fronting business, where it retains a minority share of the risk and seek to earn fee income by allowing other carriers and producers to use its licensure, ratings, expertise and infrastructure, and the Corporate and other segment consists of the management and treasury activities of holding companies, and equity compensation for the group.

About HRTX Heron Therapeutics Inc.

Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.

Share on Social Networks: